PRPO
Precipio, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$23.40-5.03%
Price as of Jul 20, 2026
PRPO financials
Precipio, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $24.0M | $16.0M | $15.2M | $9.4M |
| Cost of revenue | $13.3M | $8.4M | $9.2M | $6.9M |
| Gross profit | $10.7M | $7.6M | $6.0M | $2.5M |
| Operating expenses | $11.9M | $11.8M | $13.6M | $15.3M |
| Operating income | -$1.2M | -$4.2M | -$7.6M | -$12.8M |
| Net income | -$363.0K | -$4.3M | -$5.9M | -$12.2M |
| EBITDA | $1.5M | -$2.7M | -$4.5M | -$10.6M |
| Basic EPS | $-0.23 | $-2.93 | $-4.51 | $-10.73 |
| Diluted EPS | $-0.23 | $-2.93 | $-4.51 | $-10.73 |
| Balance sheet | ||||
| Cash & equivalents | $6.0M | $1.4M | $1.5M | $3.4M |
| Total assets | $21.3M | $17.0M | $18.1M | $21.5M |
| Total liabilities | $6.8M | $4.9M | $3.7M | $5.1M |
| Stockholders’ equity | $14.6M | $12.1M | $14.4M | $16.3M |
| Total debt | $3.7M | $1.3M | $1.1M | $1.4M |
| Net debt | -$2.4M | -$136.0K | -$386.0K | -$2.1M |
| Cash flow | ||||
| Operating cash flow | $685.0K | $439.0K | -$3.6M | -$7.7M |
| Capital expenditure | -$326.0K | -$223.0K | -$126.0K | -$277.0K |
| Free cash flow | $359.0K | $216.0K | -$3.7M | -$8.0M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |